Article contents
A Controlled Trial of Mebanazine (‘Actomol’) in Depression
Published online by Cambridge University Press: 29 January 2018
Extract
Mebanazine (‘Actomol’) introduced in 1960 for the treatment of depression is a monoamine-oxidase inhibitor hydrazine derivative having the following structural formula:
- Type
- Research Article
- Information
- Copyright
- Copyright © Royal College of Psychiatrists, 1965
References
- 3
- Cited by
eLetters
No eLetters have been published for this article.